Vanguard Group Inc Amneal Pharmaceuticals, Inc. Transaction History

Vanguard Group Inc

$6.44 Trillion
Q3 2025

A detailed history of Vanguard Group Inc transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 17,954,973 shares of AMRX stock, worth $209 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,954,973

Previous 17,551,391 2.3%

Holding current value

$209 Million

Previous $142 Million 26.58%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	BUY	$7.82 - $10.09 $3.16 Million - $4.07 Million	403,582 Added 2.3%	17,954,973 $180 Million
Q2 2025 Aug 11, 2025	BUY	$6.97 - $8.23 $12.5 Million - $14.7 Million	1,788,664 Added 11.35%	17,551,391 $142 Million
Q1 2025 May 09, 2025	BUY	$7.72 - $9.01 $7.11 Million - $8.3 Million	920,758 Added 6.2%	15,762,727 $132 Million
Q4 2024 Feb 11, 2025	BUY	$7.69 - $9.25 $1.68 Million - $2.02 Million	218,025 Added 1.49%	14,841,969 $118 Million
Q3 2024 Nov 13, 2024	BUY	$6.42 - $8.83 $4.04 Million - $5.56 Million	629,766 Added 4.5%	14,623,944 $122 Million
Q2 2024 Aug 13, 2024	BUY	$5.36 - $7.11 $1.43 Million - $1.89 Million	265,945 Added 1.94%	13,994,178 $88.9 Million
Q1 2024 May 10, 2024	BUY	$5.24 - $6.34 $449,833 - $544,263	85,846 Added 0.63%	13,728,233 $83.2 Million
Q4 2023 Feb 14, 2024	BUY	$3.36 - $6.21 $316,132 - $584,280	94,087 Added 0.69%	13,642,387 $82.8 Million
Q3 2023 Nov 14, 2023	BUY	$2.76 - $4.59 $1.14 Million - $1.89 Million	412,599 Added 3.14%	13,548,300 $57.2 Million
Q2 2023 Aug 14, 2023	SELL	$1.33 - $3.1 $188,480 - $439,316	-141,715 Reduced 1.07%	13,135,701 $40.7 Million
Q1 2023 May 15, 2023	BUY	$1.27 - $2.7 $291,271 - $619,239	229,348 Added 1.76%	13,277,416 $18.5 Million
Q4 2022 Feb 10, 2023	BUY	$1.96 - $2.61 $418,897 - $557,817	213,723 Added 1.67%	13,048,068 $26 Million
Q3 2022 Nov 14, 2022	BUY	$2.02 - $3.62 $367,407 - $658,423	181,885 Added 1.44%	12,834,345 $25.9 Million
Q2 2022 Aug 12, 2022	SELL	$3.01 - $4.46 $535,515 - $793,487	-177,912 Reduced 1.39%	12,652,460 $40.2 Million
Q1 2022 May 13, 2022	BUY	$3.9 - $4.89 $4.9 Million - $6.14 Million	1,255,477 Added 10.85%	12,830,372 $53.5 Million
Q4 2021 Feb 14, 2022	BUY	$3.95 - $5.85 $1.24 Million - $1.84 Million	315,036 Added 2.8%	11,574,895 $55.4 Million
Q3 2021 Nov 12, 2021	SELL	$4.31 - $5.64 $1.02 Million - $1.34 Million	-236,808 Reduced 2.06%	11,259,859 $60.1 Million
Q2 2021 Aug 13, 2021	BUY	$5.12 - $6.82 $58.9 Million - $78.4 Million	11,496,667 New	11,496,667 $58.9 Million

Others Institutions Holding AMRX

# of Institutions

259

Shares Held

150M

Call Options Held

357K

Put Options Held

View Full List

About Amneal Pharmaceuticals, Inc.

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.76B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

More about AMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Amneal Pharmaceuticals, Inc. Transaction History